Yearly Archives: 2020

COVID-19 Update

Posted on March 26, 2020 by OxfordBio

I want to reassure you that Oxford Biosciences remains operational, with our business continuing to support all our clients. We are continuing to certify vital hand sanitiser and cleansing products for our clients in the UK, and throughout the world.…

Posted in Regulatory

Status of COVID-19

Posted on March 20, 2020 by OxfordBio

From our government’s website: High consequence infectious diseases (HCID) Guidance and information about high consequence infectious diseases and their management in England. As of 19 March 2020, COVID-19 is no longer considered to be a high consequence infectious diseases (HCID)…

Posted in Regulatory

J&J ordered to pay US$750M in punitive damages over talc

Posted on February 10, 2020 by OxfordBio

Johnson & Johnson was ordered by a New Jersey jury to pay an additional US$750 million in punitive damages to a group of former Baby Powder users who had already been awarded US$37.2 million as compensation for cancers they blamed…

Posted in Regulatory

Coronavirus hit to beauty sector will be worse than SARS

Posted on February 6, 2020 by OxfordBio

Estee Lauder and L’Oreal lower profit outlook Cosmetics companies Estee Lauder and L’Oreal said they’ve taken financial hits because of the outbreak. Estee Lauder lowered its profit outlook fiscal 2020 from between $5.85 and $5.93 per share to between $5.60 and $5.70 per share,…

Posted in Skincare business